Abstract
Levodopa, typically ingested chronically at high daily doses, is predictably methylated by means of a series of reactions using B vitamins, which convert methionine to homocysteine. Elevated total plasma homocysteine (tHcy), a risk factor for dementia, has been found in PD patients using levodopa. We prospectively measured the effects on plasma tHcy and B vitamins of levodopa initiation, and measured the effects of dose changes and of treatment with dopamine agonists and entacapone. We collected paired plasma samples, at baseline and again after several months treatment, from patients initiating levodopa (n = 30), from patients whose levodopa dose was doubled (n = 15), halved or stopped (n = 14), from patients starting or stopping entacapone (n = 15) and from patients initiating or doubling dopamine agonist monotherapy (n = 16). Vitamin B12, folate, and tHcy concentrations were measured. Baseline tHcy concentration of 8.7 (2.8) micromol/L increased to 10.1 (3.1) micromol/L (P = 0.004) an average of 94 (range 36 to 200) days after initiation of 604 (240 to 1050) mg/day of L-dopa. Average concentration of vitamin B12 fell from 380 to 291 pmol/ L (P = 0.01). Patients who doubled their daily levodopa dose experienced tHcy elevation...Continue Reading
References
Apr 19, 1991·Journal of Chromatography·J B UbbinkS Bissbort
Feb 1, 1987·Neurology·A H RajputL T Kurland
Oct 1, 1972·American Journal of Epidemiology·I I Kessler
Feb 1, 1997·Clinical Neuropharmacology·J W MillerJ A Joseph
Nov 21, 1997·Journal of Internal Medicine·M L BotsD E Grobbee
Nov 14, 1998·European Neurology·W KuhnT Müller
Dec 5, 1998·Journal of Neurology·W KuhnT Müller
Jul 9, 1999·Journal of Neuroscience Research·W Duan, M P Mattson
Jul 17, 1999·Lancet·T MüllerW Kuhn
Sep 4, 1999·Annals of Internal Medicine·A G BostomP A Wolf
Aug 10, 2000·Neurology·K YasuiK Nakashima
Mar 29, 2001·Neurology·D AarslandP Kragh-Sørensen
Jan 18, 2002·Journal of Neurochemistry·Wenzhen DuanMark P Mattson
Feb 15, 2002·The New England Journal of Medicine·Sudha SeshadriPhilip A Wolf
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Frank L MastagliaByron A Kakulas
Nov 13, 2002·Neurology·N D PrinsUNKNOWN Rotterdam Scan Study
Nov 27, 2002·The American Journal of Psychiatry·Henning TiemeierMonique M B Breteler
Dec 13, 2002·Brain : a Journal of Neurology·T den HeijerM M B Breteler
Jan 21, 2003·Archives of Neurology·John D RogersRamon Diaz-Arrastia
Mar 4, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Paul S AisenMary Sano
Apr 12, 2003·Neurology·J W MillerP A Wolf
Jun 17, 2003·Acta Neurologica Scandinavica·K YasuiK Nakashima
Citations
Jan 6, 2010·Calcified Tissue International·Seung Hun LeeJung-Min Koh
Jun 8, 2006·European Journal of Clinical Pharmacology·Thomas Müller, Wilfried Kuhn
May 14, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Martin NevrlyPetr Hlustik
Apr 9, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stewart A Factor
Aug 17, 2006·Nutritional Neuroscience·Antonio SiniscalchiGiovambattista De Sarro
Jun 15, 2006·Clinical Neuropharmacology·Theresa A ZesiewiczRobert A Hauser
Nov 11, 2006·Clinical Neuropharmacology·Sharon Hassin-BaerDavid Tanne
Jan 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·V BelcastroN Tambasco
Nov 28, 2009·Gut Pathogens·André CharlettIngvar T Bjarnason
Oct 4, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Livrea
Jun 17, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Livrea
May 28, 2010·Neuropsychiatric Disease and Treatment·Steven F Werder
Oct 5, 2007·Neuromolecular Medicine·D CaccamoP Calabresi
May 1, 2009·Journal of Movement Disorders·Hae-Won Shin, Young Ho Sohn
Mar 13, 2014·Expert Opinion on Drug Safety·Wolfgang H Jost
Aug 6, 2016·BioMed Research International·Bilge KocerSelim Selcuk Comoglu
Jul 1, 2016·The International Journal of Neuroscience·Cristina TassorelliGiorgio Sandrini
Aug 20, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Teodoro Bottiglieri
Dec 7, 2007·Parkinsonism & Related Disorders·Nikolaos I TriantafyllouDimitrios Vassilopoulos
Dec 22, 2005·Parkinsonism & Related Disorders·Padraig E O'SuilleabhainRamon Diaz-Arrastia
Jun 16, 2006·Journal of the Neurological Sciences·Zoran TodorovićVladimir Kostić
Aug 27, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Jung Han YoonPhil Hyu Lee
Sep 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Cory TothDouglas Zochodne
Oct 28, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Richard M CamicioliMartin J Somerville
May 29, 2008·Expert Review of Neurotherapeutics·Thomas Müller
Jun 29, 2011·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Carla Manuela Crispim NascimentoLilian Teresa Bucken Gobbi
Apr 23, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Stuart J McCarterWolfgang Singer
Oct 30, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Lamberti
Apr 3, 2020·Expert Opinion on Drug Metabolism & Toxicology·Thomas Müller
Nov 26, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Seung Hun LeeSun Ju Chung
Aug 2, 2017·Journal of Parkinson's Disease·Mattias AndréassonPer Svenningsson
Jun 12, 2021·Advances in Nutrition·Jikke T Boelens KeunOndine van de Rest